Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Clin Microbiol Infect ; 24(9): 964-969, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29621616

ABSTRACT

BACKGROUND: Despite the development of new microbiologic technologies, blood cultures (BCs) remain the first-line tool for the diagnosis of bloodstream infections. Their diagnostic value may be affected when a microorganism of questionable evidence is isolated-for example, coagulase-negative staphylococci, Bacillus spp., viridans group streptococci, Corynebacterium spp., Propionibacterium spp. and Micrococcus spp. Finally, making a correct diagnosis of pathogenicity (vs. contamination) is challenging. AIMS: To review the current ways of dealing with the problem of BC contaminants (BCCs) and to provide practical suggestions to decrease BCC rates. SOURCES: PubMed electronic databases and existing reviews were searched up to December 2017 to retrieve relevant publications related to the topic. CONTENTS: This review describes the burden of BCC and analyses the main current issues and controversies in interpreting the occurrence of potential BC contaminants. It focuses on the best-described approaches to decide whether BCC is present and discusses the different strategies of prevention in adults. IMPLICATIONS: Each institution should have an efficient policy to prevent BCC, emphasizing the importance of following guidelines for prescribing and collecting BCs. Training healthcare workers should focus on detrimental influence on patient care and highlight the work and costs due to contaminants. The accurate differentiation of a contaminant from a true pathogen relies on a multidisciplinary approach and the clinical judgement of experienced practitioners.


Subject(s)
Bacteriological Techniques/standards , Blood Culture/standards , Clinical Laboratory Services/standards , Health Personnel/education , Humans
2.
Transpl Infect Dis ; 18(3): 461-465, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26929435

ABSTRACT

Cryptococcosis is a major concern in organ transplant recipients. A decrease in immunosuppressants following the initiation of antifungal therapy is currently recommended, but can occasionally be complicated by the onset of immune reconstitution inflammatory syndrome (IRIS). We report on a case of cryptococcosis in a kidney transplant recipient, compounded by severe neurological IRIS, the outcome of which was unfavorable despite the use of anti-tumor necrosis factor-alpha monoclonal antibodies.

3.
Med Mal Infect ; 45(5): 169-72, 2015 May.
Article in English | MEDLINE | ID: mdl-25845927

ABSTRACT

PURPOSE: We determined the prevalence of ESBL Enterobacteriaceae in urinary tract infections among inpatients, identified risk factors of acquisition, and evaluated the effectiveness of alternatives to carbapenems. METHODS: The clinical, microbiological, and therapeutic data as well as the outcomes were recorded for all ESBL-E positive urine samples for three months. RESULTS: Thirty-one (4%) of the 762 Enterobacteriaceae positive cultures were ESBL producers. The predisposing conditions for being infected with those strains were: immunodepression (61%), recent hospitalization (52%), recent antibiotic therapy (52%), and urinary catheterization (61%). 19% of infections were community acquired. The seven cases of acute pyelonephritis and five of prostatitis were treated with piperacillin-tazobactam (5), fluoroquinolones (4), ceftazidime (2), or carbapenems (only 1) after specialized advice. Four (33%) patients relapsed at week 10: three were immunodepressed and three presented with bacteremia. CONCLUSIONS: Alternatives to carbapenems (especially piperacillin-tazobactam) seem to be a good option for non-bacteremic UTI in immunocompetent patients.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Proteins/physiology , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae/enzymology , Urinary Tract Infections/drug therapy , beta-Lactam Resistance , beta-Lactamases/physiology , Adult , Aged , Anti-Bacterial Agents/classification , Catheter-Related Infections/drug therapy , Catheter-Related Infections/microbiology , Ceftazidime/therapeutic use , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Cross Infection/drug therapy , Cross Infection/microbiology , Enterobacteriaceae/drug effects , Enterobacteriaceae Infections/microbiology , Female , Fluoroquinolones/therapeutic use , Hospitalization , Hospitals, University , Humans , Immunocompromised Host , Male , Middle Aged , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/therapeutic use , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Prevalence , Prostatitis/drug therapy , Prostatitis/microbiology , Recurrence , Retrospective Studies , Risk Factors , Urinary Tract Infections/microbiology , Young Adult
4.
Clin Microbiol Infect ; 20(11): O920-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24766148

ABSTRACT

Detection of microorganisms by blood cultures (BCs) is essential in managing patients with bacteraemia. Rather than the number of punctures, the volume of blood drawn is considered paramount in efficient and reliable detection of microorganisms. We performed a 1-year prospective multicentre study in adult emergency departments of three French university hospitals comparing two methods for BCs: a unique blood culture (UBC) collecting a large volume of blood (40 mL) and the standard method of multiple blood cultures (MBC). The performances of both methods for bacterial contamination and efficient microbial detection were compared, each patient serving as his own control. Amongst the 2314 patients included, three hundred were positive for pathogens (n=245) or contaminants (n=55). Out of the 245 patients, 11 were positive for pathogens by UBC but negative by MBC and seven negative by UBC but positive by MBC (p 0.480). In the subgroup of 137 patients with only two BCs, UBC was superior to MBC (p 0.044). Seven and 17 patients had contaminated BCs by UBC and MBC only, respectively (p 0.062). Considering the sums of pathogens missed and contaminants, UBC significantly outperformed MBC (p 0.045). Considering the complete picture of cost savings, efficient detection of microorganisms and decrease in contaminations, UBC offers an interesting alternative to MBC.


Subject(s)
Bacteremia/diagnosis , Bacteriological Techniques/methods , Blood/microbiology , Emergency Medicine/methods , Specimen Handling/methods , Adolescent , Adult , Aged , Aged, 80 and over , Emergency Service, Hospital , Female , France , Hospitals, University , Humans , Male , Middle Aged , Prospective Studies , Young Adult
5.
Med Mal Infect ; 43(7): 299-301, 2013 Jul.
Article in French | MEDLINE | ID: mdl-23895742
6.
Transpl Infect Dis ; 14(6): E147-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23025483

ABSTRACT

Microsporidiosis is an opportunistic infection in organ transplant recipients and patients with other cellular immunodeficiency. Fumagillin is an effective treatment against Enterocytozoon bieneusi, one of the two main species causing the microsporidiosis involved in human diseases. We report the first case, to our knowledge, of a probable drug-induced aseptic meningoencephalitis, after administration of fumagillin in a kidney transplant recipient with microsporidiosis.


Subject(s)
Antifungal Agents/adverse effects , Cyclohexanes/adverse effects , Fatty Acids, Unsaturated/adverse effects , Kidney Transplantation/adverse effects , Meningoencephalitis/etiology , Microsporidiosis/drug therapy , Cyclohexanes/therapeutic use , Fatty Acids, Unsaturated/therapeutic use , Female , Humans , Immunocompromised Host , Middle Aged , Sesquiterpenes/adverse effects , Sesquiterpenes/therapeutic use
8.
Med Mal Infect ; 41(3): 160-3, 2011 Mar.
Article in French | MEDLINE | ID: mdl-21195570
9.
Med Mal Infect ; 39(12): 877-85, 2009 Dec.
Article in French | MEDLINE | ID: mdl-19346088

ABSTRACT

OBJECTIVE: A one-year prospective, observational study was conducted in the west of France, to evaluate the epidemiology of candidemia. METHOD: During the year 2004, each patient with at least one blood culture yielding Candida sp. was included. For each episode of candidemia, mycological, demographical, clinical, and therapeutic data, as well as outcome, were collected. RESULTS: One hundred and ninety-three strains of Candida sp. were isolated in 186 patients, Candida albicans accounting for 54.9%, Candida glabrata for 18.7%, Candida parapsilosis for 12.9%, Candida tropicalis for 4.7% and Candida krusei for 4.1% of these isolates. A percentage of 84% of the Candida isolates were fully susceptible to fluconazole in vitro. Dose-dependent susceptibility or resistance to fluconazole was detected in more than one third of the Candida glabrata strains, of which 36% were also resistant to voriconazole. Two-thirds of the patients were males, and the mean age was 61.5 years. A percentage of 37% of patients were hospitalized in intensive care units. The main predisposing factors for candidemia were broad-spectrum antibiotics (75.8%), central venous catheter (72.6%), cancer or hematologic malignancy (47.3%), recent surgery (42.5%), total parenteral nutrition (37.6%). One hundred and fifty-four patients were treated with antifungal therapy, two-thirds of whom received fluconazole as first-line agent. Mortality was 49% overall, and was significantly higher in case of septic shock, advanced age, and absence of catheter removal.


Subject(s)
Candidiasis/epidemiology , Fungemia/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Candida/classification , Candida/drug effects , Candida/isolation & purification , Candidiasis/drug therapy , Candidiasis/microbiology , Catheter-Related Infections/epidemiology , Catheter-Related Infections/microbiology , Catheterization, Central Venous/adverse effects , Child , Child, Preschool , Comorbidity , Cross Infection/epidemiology , Cross Infection/microbiology , Drug Resistance, Multiple, Fungal , France/epidemiology , Fungemia/drug therapy , Fungemia/microbiology , Humans , Infant , Infant, Newborn , Middle Aged , Neoplasms/epidemiology , Parenteral Nutrition , Postoperative Complications/epidemiology , Postoperative Complications/microbiology , Prospective Studies , Risk Factors , Superinfection/epidemiology , Superinfection/microbiology , Young Adult
10.
Gastroenterol Clin Biol ; 32(12): 1077-91, 2008 Dec.
Article in French | MEDLINE | ID: mdl-19019604

ABSTRACT

Pyogenic-liver abscesses are due to bacteria mostly from the portal and biliary tracts. There is usually only one located in the right liver, but they may be found in the left liver, be multiple or multilocular. Diagnosis, based on ultrasound and/or computed tomography scan, is confirmed by percutaneous-needle aspiration to identify the bacteria causing the disease. Global management includes the treatment of sepsis and the aetiology of the liver abscess: biliary lithiasis, diverticular disease, colon cancer, appendicitis or other intra-abdominal infections. However, no cause is found in 20% of cases. Treatment is based on antibiotics and, sometimes, percutaneous drainage while the cause may be treated immediately or later if the sepsis is controlled. Interventional radiology is often used. Surgery may be performed in case of failure of initial treatment and to cure the cause of the abscess. Prognosis may be poor, especially if there are associated-risk factors, such as diabetes and immunodepression, even though the outcome has improved with a multidisciplinary approach.


Subject(s)
Liver Abscess, Pyogenic/diagnosis , Liver Abscess, Pyogenic/therapy , Decision Trees , Humans , Suppuration
11.
Rev Med Interne ; 27(11): 892-4, 2006 Nov.
Article in French | MEDLINE | ID: mdl-16854507

ABSTRACT

INTRODUCTION: Herpetic meningoencephalitis is treated with acyclovir (15 mg/kg/8 h). This higher dosage enhance the risk of acute renal failure. CASE REPORT: We report the case of a previously healthy 42 years old man treated by intravenous aciclovir 1g/8 h for a herpetic meningoencephalitis. He presented an acute renal failure and an acute confusional state at the end of the treatment. Renal function and neurologic status improved rapidly with increased hydration and stop of the antiviral therapy. CONCLUSION: If acyclovir is usually well tolerated, there is also a risk of acute nephropathy, especially dose-dependent. We point out the need to monitor renal function when high dosage of acyclovir is indicated.


Subject(s)
Acute Kidney Injury/chemically induced , Acyclovir/adverse effects , Antiviral Agents/adverse effects , Acyclovir/administration & dosage , Adult , Antiviral Agents/administration & dosage , Encephalitis, Herpes Simplex/drug therapy , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL